Results 71 to 80 of about 670,718 (407)

Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer.

open access: yesACS Nano, 2018
Prostate cancer is one of the most common cancers and among the leading causes of cancer deaths in the United States. Men diagnosed with the disease typically undergo radical prostatectomy, which often results in incontinence and impotence. Recurrence of
J. Mangadlao   +8 more
semanticscholar   +1 more source

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini   +11 more
wiley   +1 more source

Prostate Specific Antigen (PSA) Inisial ? 100 Ng/ml Menggambarkan Stadium Lanjut Dan Rendahnya Survival Kanker Prostat [PDF]

open access: yes, 2011
Prostate Specific Antigen(PSA) merupakanmarkeryang penting dalam diagnosis,follow up, dan menentukan prognosis kanker prostat. Penggunaan PSA sebagai skrining telah menurunkan kejadian kanker prostat stadium lanjut saat terdiagnosis.
Mochtar, C. A. (Chaidir)   +2 more
core  

Measurement of serum total and free prostate-specific antigen in women with colorectal carcinoma [PDF]

open access: yes
We investigated the diagnostic value and the relationship with clinicopathological features of total and free prostate-specific antigen by measuring the concentrations of these markers in the sera of 75 women with colorectal carcinoma and in 30 healthy ...
CYF Young   +24 more
core   +2 more sources

Estimate of Opportunistic Prostate Specific Antigen Testing in the Finnish Randomized Study of Screening for Prostate Cancer [PDF]

open access: yes, 2017
Purpose: Screening for prostate cancer remains controversial, although ERSPC (European Randomized Study of Screening for Prostate Cancer) showed a 21% relative reduction in prostate cancer mortality. The Finnish Randomized Study of Screening for Prostate
Auvinen, Anssi   +8 more
core   +1 more source

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

open access: yesMolecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi   +6 more
wiley   +1 more source

Effect of Temperature and Humidity on Serum Prostate Specific Antigen Levels in Asymptomatic Male Population

open access: yesJournal of Urological Surgery, 2016
Objective To determine the possible effect of climate parameters on prostate specific anigen (PSA) levels. Materials and Methods Among 2.150 males, 757 individuals participating in a general check-up service at our hospital group in the past one year ...
Murat Tuğrul Eren   +2 more
doaj   +1 more source

Prevalence and factors associated to incidental prostate carcinoma among patients undergoing turp for benign prostatic enlargement. [PDF]

open access: yes, 2020
Background: Prostate carcinoma carries higher morbidity and mortality when diagnosed late. Prostate cancer screening is paramount, however, there are no specific clinical signs for early-stage prostate cancer.
Mawalla, Isaac Herman
core   +1 more source

All care, but whose responsibility? Community juries reason about expert and patient responsibilities in prostate-specific antigen screening for prostate cancer [PDF]

open access: yes, 2016
General practitioners have implicitly been given responsibility for guiding men’s decisions about prostate-specific antigen–based screening for prostate cancer, but patients’ expectations of the bounds of this responsibility remain unclear.
Carter, S, Degeling, C, Rychetnik, L
core   +3 more sources

Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patients

open access: yesMolecular Oncology, EarlyView.
We quantified and cultured circulating tumor cells (CTCs) of 62 patients with various cancer types and generated CTC‐derived tumoroid models from two salivary gland cancer patients. Cellular liquid biopsy‐derived information enabled molecular genetic assessment of systemic disease heterogeneity and functional testing for therapy selection in both ...
Nataša Stojanović Gužvić   +31 more
wiley   +1 more source

Home - About - Disclaimer - Privacy